151 related articles for article (PubMed ID: 12533171)
1. Cutaneous reactions to chemotherapy drugs: the art of consultation.
Remlinger KA
Arch Dermatol; 2003 Jan; 139(1):77-81. PubMed ID: 12533171
[No Abstract] [Full Text] [Related]
2. Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent.
Zimmerman GC; Keeling JH; Burris HA; Cook G; Irvin R; Kuhn J; McCollough ML; Von Hoff DD
Arch Dermatol; 1995 Feb; 131(2):202-6. PubMed ID: 7857119
[TBL] [Abstract][Full Text] [Related]
3. Nail changes due to docetaxel.
Pavithran K; Doval DC
Br J Dermatol; 2002 Apr; 146(4):709-10. PubMed ID: 11966714
[No Abstract] [Full Text] [Related]
4. Cutaneous adverse reactions to chemotherapy with taxanes: the dermatologist's point of view.
Donati A; Castro LG
An Bras Dermatol; 2011; 86(4):755-8. PubMed ID: 21987144
[TBL] [Abstract][Full Text] [Related]
5. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study.
Cardoso F; Ferreira Filho AF; Crown J; Dolci S; Paesmans M; Riva A; Di Leo A; Piccart MJ
Anticancer Res; 2001; 21(1B):789-95. PubMed ID: 11299845
[TBL] [Abstract][Full Text] [Related]
7. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.
Yeo W; Leung SF; Johnson PJ
Eur J Cancer; 1997 Apr; 33(4):698-9. PubMed ID: 9274459
[No Abstract] [Full Text] [Related]
8. Cutaneous fibrosis induced by docetaxel: a case report.
Cleveland MG; Ajaikumar BS; Reganti R
Cancer; 2000 Mar; 88(5):1078-81. PubMed ID: 10699898
[TBL] [Abstract][Full Text] [Related]
9. Subungual abscess: a new ungual side-effect related to docetaxel therapy.
Vanhooteghem O; Richert B; Vindevoghel A; Vandenbossche L; Vandeveire A; de la Brassinne M
Br J Dermatol; 2000 Aug; 143(2):462-4. PubMed ID: 10951175
[No Abstract] [Full Text] [Related]
10. Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy.
Dourakis SP; Sevastianos VA; Alexopoulou A; Deutsch M; Stavrianeas N
J Clin Oncol; 2002 Jul; 20(13):3030-2. PubMed ID: 12089234
[No Abstract] [Full Text] [Related]
11. Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.
Chen GY; Chang TW; Chen WC
Br J Dermatol; 2003 May; 148(5):1071-3. PubMed ID: 12786853
[No Abstract] [Full Text] [Related]
12. Local erythematous dermatitis after intravenous docetaxel.
Hirai K; Ishiko O; Nakajima S; Kanaoka Y; Nakamura Y; Oiso N; Ishii M; Ogita S
Gynecol Obstet Invest; 2002; 53(2):118-20. PubMed ID: 11961387
[TBL] [Abstract][Full Text] [Related]
13. Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Levantine A; Almeyda J
Br J Dermatol; 1974 Feb; 90(2):239-42. PubMed ID: 4132051
[No Abstract] [Full Text] [Related]
14. Cutaneous hand and foot toxicity associated with cancer chemotherapy.
Childress J; Lokich J
Am J Clin Oncol; 2003 Oct; 26(5):435-6. PubMed ID: 14528066
[No Abstract] [Full Text] [Related]
15. Dermatological adverse events with taxane chemotherapy.
Sibaud V; Lebœuf NR; Roche H; Belum VR; Gladieff L; Deslandres M; Montastruc M; Eche A; Vigarios E; Dalenc F; Lacouture ME
Eur J Dermatol; 2016 Oct; 26(5):427-443. PubMed ID: 27550571
[TBL] [Abstract][Full Text] [Related]
16. Flagellate erythema induced by docetaxel.
Tallon B; Lamb S
Clin Exp Dermatol; 2008 May; 33(3):276-7. PubMed ID: 18201264
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.
Chan S; Friedrichs K; Noel D; Pintér T; Van Belle S; Vorobiof D; Duarte R; Gil Gil M; Bodrogi I; Murray E; Yelle L; von Minckwitz G; Korec S; Simmonds P; Buzzi F; González Mancha R; Richardson G; Walpole E; Ronzoni M; Murawsky M; Alakl M; Riva A; Crown J;
J Clin Oncol; 1999 Aug; 17(8):2341-54. PubMed ID: 10561296
[TBL] [Abstract][Full Text] [Related]
18. Persistent docetaxel-induced supravenous erythematous eruption.
Fernandes Kde A; Felix PA
An Bras Dermatol; 2015; 90(5):728-30. PubMed ID: 26560218
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.
Piccart MJ; Klijn J; Paridaens R; Nooij M; Mauriac L; Coleman R; Bontenbal M; Awada A; Selleslags J; Van Vreckem A; Van Glabbeke M
J Clin Oncol; 1997 Sep; 15(9):3149-55. PubMed ID: 9294478
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
Verweij J; Lee SM; Ruka W; Buesa J; Coleman R; van Hoessel R; Seynaeve C; di Paola ED; van Glabbeke M; Tonelli D; Judson IR
J Clin Oncol; 2000 May; 18(10):2081-6. PubMed ID: 10811673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
